Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that can cause a debilitating disease that is primarily characterized by persistent joint pain. CHIKV has been emerging globally, while neither a vaccine nor antiviral medication is available. The anti-parasitic drug suramin was previous...
Main Authors: | Irina C. Albulescu, Leonie White-Scholten, Ali Tas, Tabitha E. Hoornweg, Salvatore Ferla, Kristina Kovacikova, Jolanda M. Smit, Andrea Brancale, Eric J. Snijder, Martijn J. van Hemert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/3/314 |
Similar Items
-
Chikungunya triggers an autophagic process which promotes viral replication
by: Briant Laurence, et al.
Published: (2011-09-01) -
Transcontinental Movement of Asian Genotype Chikungunya Virus
by: Robert S. Lanciotti, et al.
Published: (2014-08-01) -
Cerebrospinal Fluid Immunoglobulins as Potential Biomarkers of Chikungunya Encephalitis
by: Marzia Puccioni-Sohler, et al.
Published: (2018-05-01) -
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
by: Lana Langendries, et al.
Published: (2021-03-01) -
The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
by: Jared Kirui, et al.
Published: (2021-07-01)